Hot Stocks

Hot stocks are not about hype. They emerge when powerful themes, policy shifts, and capital flows converge. InvestorPlace analysts track fast-moving market narratives, especially in technology, AI, and infrastructure, to identify stocks drawing outsized attention and explain what is really driving those moves.

Why Apple Stock Investors Are Living Dangerously

AAPL stock has more than doubled since its March lows. Here's why investors may be starting to live on borrowed time on this blue-chip stock.

Workhorse’s Valuation Has Gotten Ahead of Itself

Investor optimism about the future of WKHS stock is already baked into its shareprice, making it a risky play with quite a few unknowns.

Genworth Financial News: GNW Stock Flies 32% on Oceanwide Financing

Genworth Financial (GNW) news for Monday includes reports that Oceanwide has finally secured financing to acquire the company.

GameStop News: GME Stock Gets Goosed 30% by Chewy Co-Founder Stake

GameStop (GME) is in the news Monday after revealing that Chewy co-founder Ryan Cohen has taken out a significant stake in the company.

A New Capital Raise Will Help Nio Stock Ride the EV Wave

Nio went from the edge of bankruptcy to an EV darling seemingly overnight. If you like Nio stock, get excited over its equity capital raise.

Intel News: INTC Stock Pops 2% on Tiger Lake Chips Leak

Intel (INTC) news for Monday concerning leaked data from its upcoming Tiger Lake chips for laptops have INTC stock heading higher,

Why Johnson & Johnson Remains a Risky Bet

Johnson & Johnson is financial fortress. That doesn’t mean that you can buy JNJ stock, throw it in a drawer, and forget about it.

Is The Party Over for Inovio Stock? It Depends

Nevertheless, while it's not out of the running just yet, it may be best not to take a gamble with INO stock. Sit on the sidelines for now, and wait for a more compelling entry point.

Aimmune Therapeutics News: Why AIMT Stock Is Skyrocketing Today

Aimmune Therapeutics' news of its agreement with Nestle regarding its food allergy treatment has AIMT stock soaring way higher on Monday.

Royalty Pharma Stock Should Be Moving Off Your Watchlist

Royalty Pharma stock has faded after rallying immediately after its IPO. With valuation more reasonable, RPRX has a solid long-term case.

Slack Stock Is At an Inflection Point And Looks Expensive Here

Slack is at an inflection point with growing free cash flow. Slack stock assumes sales will grow over 33% annually over the next 3 years.

Sorrento Stock Looks Volatile on Drama and FDA’s Covid-19 Moves

Sorrento Technologies saw its stock make big gains based on its suite of Covid-19 solutions, but SRNE stock has been pummeled in August.

Make Sure You Understand the Risks Before Speculating on Ocugen Stock

Ocugen is raising cash through its orphan drug designation, but it still faces risks. Make sure you treat OCGN stock as a speculation.

Toss Taoping Stock Off Your Watch List Despite Cloud Connection

At the intersection of big data and cloud management stands this Chinese start-up. That sounds promising, but Taoping stock is falling fast.

General Electric Doubles Down on Superstar CEO Larry Culp

General Electric's return to profitability keeps getting delayed. However, the company's management isn't giving up on GE stock yet.

3 Reasons to Leave Kandi Technologies Group in the Garage

With so many competitors in the electric vehicle market, KNDI stock has a great initial story – provide economical EVs for lower-income drivers. But the finer details make this a trickier investment than you might think.

Nio May Be Shooting Past Its Fundamentals

With electric vehicles gaining substantial momentum, it makes sense that Nio stock has skyrocketed. However, it’s also fair to ask if shares aren’t a bit stretched at the moment.

Zoom Video Releases Q2 Results: What To Expect From ZM Stock in September

ZM stock may come under pressure short-term, but shares in the video communications specialist are likely to reach new highs in the coming quarters

Sorrento’s Covid-19 Test, Acquisitions Should Help SRNE Stock Surge

Sorrento's COVID-19 test appears to be superior to competing diagnostics, and it just made a good acquisition, while its overall strategy is sound.